BDBM419185 5-tert-Butyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methyl]-7-(1,2,5-triazaspiro[2.4]hept-1-en-5-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine::US10457684, Example 1

SMILES Cc1nonc1Cn1nnc2c(nc(nc12)C(C)(C)C)N1CCC2(C1)N=N2

InChI Key InChIKey=ABOAQKNSXAWOJU-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419185   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419185(5-tert-Butyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)met...)
Affinity DataKi:  16.1nMAssay Description:The affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419185(5-tert-Butyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)met...)
Affinity DataKi:  2.96E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent